Is Neural Therapeutics Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Neural Therapeutics Inc (NURL.CN) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Neural Therapeutics Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Neural Therapeutics Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Neural Therapeutics Inc?

Muslim investors may consider investing in Neural Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Neural Therapeutics Inc classified as NOT HALAL?

Musaffa determines the Shariah status of Neural Therapeutics Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Neural Therapeutics Inc updated?

The Shariah compliance status of Neural Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Neural Therapeutics Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Neural Therapeutics Inc?

You can check the latest Shariah compliance status of Neural Therapeutics Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

NURL.CN Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: July 16, 2025

Report Source: 2025 3rd Quarter Report

Neural Therapeutics Inc. Stock Analysis NURL.CN

Canada N/A Nano Cap Report: Q3, 2025

Neural Therapeutics, Inc. is an ethnobotanical drug-discovery company, which engages in the research and development of dietary supplements and psychedelic-based therapeutic medicines to treat mental ailments. The firm's approach to drug development involves the strategic use of sub-hallucinogenic doses of mescaline extract. Its initial focus is the San Pedro (Echinopsis pachanoi or Trichocereus pachanoi), a cactus containing mescaline. The firm has approximately 30.75% of the equity interest in CWE European Holdings Inc., the owner and operator of a business known as Hanf.com (Hanf.com), one of Germany's CBD retailers. Hanf.com's retail and eCommerce operations include 15 stores in Germany (11 directly owned and four franchises).

Key Statistics of Neural Therapeutics Inc (NURL.CN)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

CAD0.02CAD0.02

Today's Open

CAD0.02

Volume

4000.00

P/E Ratio (TTM)

52 Week Range

CAD0.01CAD0.04

Market Cap

3.37M

Avg. Volume

40.52K

Dividend Yield

Financial Metrics & Statements of Neural Therapeutics Inc (NURL.CN)

FAQ's for Neural Therapeutics Inc (NURL.CN)

According to Musaffa’s Shariah screening methodology, Neural Therapeutics Inc (NURL.CN) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.